Home » Newsletters » BioWorld Science

BioWorld Science

March 29, 2005

View Archived Issues

Minocycline decreases the need for oral steroids in adult patients with asthma

Preclinical data support development of lisofylline as a treatment for type 1 diabetes

PDE3 inhibitor shows potential clinical use as a contraceptive / News in Context

ACE BioSciences and SynCo collaborate on GMP production of ACE-393

LT-1951 enters phase I/IIa for prevention of CABG failure

FDA approves amendments to Corautus Genetics' GENASIS gene therapy trial

Preclinical study findings for Alltracel's m.doc technology platform

Colombian approval for Impavido for cutaneous leishmaniasis

BioWa licenses anti-IL-5 receptor antibody from Kyowa Hakko Kogyo

Immunization studies reveal a novel human asthma vaccine

SGS-742 evaluated in new phase II study for adult ADHD

Leukolysin: a new target for asthma

Completion of enrollment for phase I HIV vaccine trial

The PARP inhibitor INO-1001 does not affect DNA repair and cell senescence

Ventavis now available for PAH

NIM-811 as a treatment for apoptosis and myocardial mitochondrial dysfunction in sepsis

Aphton shareholders approve Igeneon acquisition

NX-1207 shows promise for BPH

U.K. clearance for phase III study of COLAL-PRED for acute ulcerative colitis

Cerepro progresses in Europe

Regulatory pathway considered for Vitor in Europe

Solvay to acquire Fournier Pharma

Cannabinoid CB1 antagonists active in advanced Parkinson's disease model

Rosiglitazone protects against experimental acute lung injury

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...